Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ANDA
Sort By
Newest First
1 / 1
1 / 1
CDMO
Redesigning ANDA or Novel Drug Products at All Stages for the U.S. Market
Tedor Pharma Services
PAO-08-23-CL-06
September 26, 2023
Generics
FDA Grants Profounda Inc. Competitive Generic Therapy (CGT) Designation for planned ANDA filing of Minocycline Hydrochloride Microspheres, 1 mg
Profounda, Inc.
PR-M10-18-NI-014
October 03, 2018
FDA
Breckenridge Wins ANDA for Azacitidine
Steve Kuehn
Nice Insight
PAO-M07-17-NI-001
July 03, 2017
